These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 9832493)

  • 1. Clopidogrel inhibition of stent, graft, and vascular thrombogenesis with antithrombotic enhancement by aspirin in nonhuman primates.
    Harker LA; Marzec UM; Kelly AB; Chronos NR; Sundell IB; Hanson SR; Herbert JM
    Circulation; 1998 Dec; 98(22):2461-9. PubMed ID: 9832493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of clopidogrel, aspirin and combined therapy in a porcine ex vivo model of high-shear induced stent thrombosis.
    Makkar RR; Eigler NL; Kaul S; Frimerman A; Nakamura M; Shah PK; Forrester JS; Herbert JM; Litvack F
    Eur Heart J; 1998 Oct; 19(10):1538-46. PubMed ID: 9820993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of turbidimetric aggregation and in vitro bleeding time (PFA-100) for monitoring the platelet inhibitory profile of antiplatelet agents in patients undergoing stent implantation.
    Van der Planken MG; Claeys MJ; Vertessen FJ; Dilling D; Bosmans JM; Berneman ZN; Michiels JJ; Vrints C
    Thromb Res; 2003; 111(3):159-64. PubMed ID: 14678814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A thromboxane A2/prostaglandin H2 receptor antagonist (S18886) shows high antithrombotic efficacy in an experimental model of stent-induced thrombosis.
    Vilahur G; Casaní L; Badimon L
    Thromb Haemost; 2007 Sep; 98(3):662-9. PubMed ID: 17849057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental thrombosis on a collagen coated arterioarterial shunt in rats: a pharmacological model to study antithrombotic agents inhibiting thrombin formation and platelet deposition.
    Freund M; Mantz F; Nicolini P; Gachet C; Mulvihill J; Meyer L; Beretz A; Cazenave JP
    Thromb Haemost; 1993 May; 69(5):515-21. PubMed ID: 8322274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pharmacodynamic study of clopidogrel in chronic hemodialysis patients.
    Kaufman JS; Fiore L; Hasbargen JA; O'Connor TZ; Perdriset G
    J Thromb Thrombolysis; 2000 Oct; 10(2):127-31. PubMed ID: 11005934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of PD0348292, a selective factor Xa inhibitor, to antiplatelet agents for the inhibition of arterial thrombosis.
    Karnicki K; Leadley RJ; Baxi S; Peterson T; Wysokinski W; McBane RD
    Thromb Haemost; 2008 Apr; 99(4):759-66. PubMed ID: 18392334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antiaggregating and antithrombotic activity of clopidogrel is potentiated by aspirin in several experimental models in the rabbit.
    Herbert JM; Dol F; Bernat A; Falotico R; Lalé A; Savi P
    Thromb Haemost; 1998 Sep; 80(3):512-8. PubMed ID: 9759636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of platelet production and function by megakaryocyte growth and development factor in nonhuman primates.
    Harker LA; Hunt P; Marzec UM; Kelly AB; Tomer A; Hanson SR; Stead RB
    Blood; 1996 Mar; 87(5):1833-44. PubMed ID: 8634430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired responsiveness to clopidogrel and aspirin in patients with recurrent stent thrombosis following percutaneous intervention for peripheral artery disease.
    Mazur P; Frołow M; Niżankowski R; Sadowski J; Undas A
    Platelets; 2013; 24(2):151-5. PubMed ID: 22497730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of GP IIb/IIIa receptor monoclonal antibody (7E3), heparin, and aspirin in an ex vivo canine arteriovenous shunt model of stent thrombosis.
    Makkar RR; Litvack F; Eigler NL; Nakamura M; Ivey PA; Forrester JS; Shah PK; Jordan RE; Kaul S
    Circulation; 1997 Feb; 95(4):1015-21. PubMed ID: 9054765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of clopidogrel and aspirin on platelet aggregation, thromboxane production, and serotonin secretion in horses.
    Brainard BM; Epstein KL; LoBato D; Kwon S; Papich MG; Moore JN
    J Vet Intern Med; 2011; 25(1):116-22. PubMed ID: 21143302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced antiplatelet effect of clopidogrel in patients whose platelets are least inhibited by aspirin: a randomized crossover trial.
    Eikelboom JW; Hankey GJ; Thom J; Claxton A; Yi Q; Gilmore G; Staton J; Barden A; Norman PE
    J Thromb Haemost; 2005 Dec; 3(12):2649-55. PubMed ID: 16359503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Razaxaban, a direct factor Xa inhibitor, in combination with aspirin and/or clopidogrel improves low-dose antithrombotic activity without enhancing bleeding liability in rabbits.
    Wong PC; Crain EJ; Watson CA; Wexler RR; Lam PY; Quan ML; Knabb RM
    J Thromb Thrombolysis; 2007 Aug; 24(1):43-51. PubMed ID: 17323133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombotic effects of TAK-029, a novel GPIIb/IIIa antagonist, in guinea pigs: comparative studies with ticlopidine, clopidogrel, aspirin, prostaglandin E1 and argatroban.
    Kawamura M; Imura Y; Moriya N; Kita S; Fukushi H; Sugihara H; Nishikawa K; Terashita Z
    J Pharmacol Exp Ther; 1996 Apr; 277(1):502-10. PubMed ID: 8613960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of laropiprant, a selective prostaglandin D₂ receptor 1 antagonist, on the antiplatelet activity of clopidogrel or aspirin.
    Dallob A; Luo WL; Luk JM; Ratcliffe L; Johnson-Levonas AO; Schwartz JI; Dishy V; Kraft WK; De Hoon JN; Van Hecken A; De Lepeleire I; Radziszewski W; Wagner JA; Lai E
    Platelets; 2011; 22(7):495-503. PubMed ID: 21526889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of targeting platelet proteinase-activated receptors in combination with existing anti-platelet drugs as antithrombotics in mice.
    Lee H; Sturgeon SA; Mountford JK; Jackson SP; Hamilton JR
    Br J Pharmacol; 2012 Aug; 166(7):2188-97. PubMed ID: 22428607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The antithrombotic effect of melagatran in combination with clopidogrel and/or aspirin (carotid artery primary thrombosis study).
    Hong TT; Huang J; Driscoll E; Lucchesi BR
    J Cardiovasc Pharmacol; 2005 Oct; 46(4):526-33. PubMed ID: 16160608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiplatelet and antithrombotic efficacy of SR 121787, a nonpeptide orally active GP IIb/IIIa antagonist, in rabbits: comparison with clopidogrel and aspirin.
    Hoffmann P; Bernat A; Savi P; Herbert JM
    J Cardiovasc Pharmacol; 1997 Sep; 30(3):360-6. PubMed ID: 9300321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet aggregometry and receptor binding to predict the magnitude of antithrombotic and bleeding time effects of clopidogrel in rabbits.
    Wong PC; Crain EJ; Watson CA; Jiang X; Hua J; Bostwick JS; Ogletree ML; Schumacher WA; Rehfuss R
    J Cardiovasc Pharmacol; 2007 May; 49(5):316-24. PubMed ID: 17513951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.